Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fiebiger

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedulesM Hejna, G V Kornek, M Raderer, et al.
Oncology|September 20, 2002
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neckC Gedlicka, M Formanek, E Selzer, et al.
British Journal of Cancer|June 27, 2002
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancerG V Kornek, M Raderer, B Schüll, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
British Journal of Cancer|November 27, 2001
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-typeM Raderer, T Traub, M Formanek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapyH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedulesM Hejna, G V Kornek, M Raderer, et al.
Oncology|September 20, 2002
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neckC Gedlicka, M Formanek, E Selzer, et al.
British Journal of Cancer|June 27, 2002
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancerG V Kornek, M Raderer, B Schüll, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
British Journal of Cancer|November 27, 2001
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-typeM Raderer, T Traub, M Formanek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapyH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
Pageof 2